In silico modeling is becoming a valuable and accurate prediction tool, despite its early, spotty reputation. The increase in information from metabolomics, proteomics, and genomics projects, plus ...
Simulations Plus' silico software boosts non-animal drug development and drives growth. Read here for an investment analysis ...
AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback